IT1265964B1 - Micro-granuli ottenuti tramite estrusione-sferonizzazione contenenti una ciclodestrina. - Google Patents

Micro-granuli ottenuti tramite estrusione-sferonizzazione contenenti una ciclodestrina.

Info

Publication number
IT1265964B1
IT1265964B1 IT94TO000406A ITTO940406A IT1265964B1 IT 1265964 B1 IT1265964 B1 IT 1265964B1 IT 94TO000406 A IT94TO000406 A IT 94TO000406A IT TO940406 A ITTO940406 A IT TO940406A IT 1265964 B1 IT1265964 B1 IT 1265964B1
Authority
IT
Italy
Prior art keywords
micro
spheronization
extrusion
cyclodextrin
granules
Prior art date
Application number
IT94TO000406A
Other languages
English (en)
Inventor
Ferdinando Giordano
Andrea Gazzaniga
Ernesto Fossati
Philippe Lefevre
Original Assignee
Roquette Freres
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Roquette Freres filed Critical Roquette Freres
Publication of ITTO940406A0 publication Critical patent/ITTO940406A0/it
Publication of ITTO940406A1 publication Critical patent/ITTO940406A1/it
Application granted granted Critical
Publication of IT1265964B1 publication Critical patent/IT1265964B1/it

Links

Classifications

    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B82—NANOTECHNOLOGY
    • B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/69—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
    • A61K47/6949—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes
    • A61K47/6951—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes using cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1682—Processes
    • A61K9/1694—Processes resulting in granules or microspheres of the matrix type containing more than 5% of excipient
    • C—CHEMISTRY; METALLURGY
    • C05—FERTILISERS; MANUFACTURE THEREOF
    • C05F—ORGANIC FERTILISERS NOT COVERED BY SUBCLASSES C05B, C05C, e.g. FERTILISERS FROM WASTE OR REFUSE
    • C05F11/00—Other organic fertilisers
    • C—CHEMISTRY; METALLURGY
    • C05—FERTILISERS; MANUFACTURE THEREOF
    • C05G—MIXTURES OF FERTILISERS COVERED INDIVIDUALLY BY DIFFERENT SUBCLASSES OF CLASS C05; MIXTURES OF ONE OR MORE FERTILISERS WITH MATERIALS NOT HAVING A SPECIFIC FERTILISING ACTIVITY, e.g. PESTICIDES, SOIL-CONDITIONERS, WETTING AGENTS; FERTILISERS CHARACTERISED BY THEIR FORM
    • C05G5/00—Fertilisers characterised by their form
    • C05G5/30—Layered or coated, e.g. dust-preventing coatings
    • C—CHEMISTRY; METALLURGY
    • C05—FERTILISERS; MANUFACTURE THEREOF
    • C05G—MIXTURES OF FERTILISERS COVERED INDIVIDUALLY BY DIFFERENT SUBCLASSES OF CLASS C05; MIXTURES OF ONE OR MORE FERTILISERS WITH MATERIALS NOT HAVING A SPECIFIC FERTILISING ACTIVITY, e.g. PESTICIDES, SOIL-CONDITIONERS, WETTING AGENTS; FERTILISERS CHARACTERISED BY THEIR FORM
    • C05G5/00—Fertilisers characterised by their form
    • C05G5/45—Form not covered by groups C05G5/10 - C05G5/18, C05G5/20 - C05G5/27, C05G5/30 - C05G5/38 or C05G5/40, e.g. soluble or permeable packaging

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pest Control & Pesticides (AREA)
  • Nanotechnology (AREA)
  • Epidemiology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Molecular Biology (AREA)
  • General Engineering & Computer Science (AREA)
  • Medical Informatics (AREA)
  • Biotechnology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Biophysics (AREA)
  • Medicinal Preparation (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

L'invenzione ha per oggetto dei micro - granuli ottenuti tramite estrusione - sferonizzazione comprendente almeno una ciclodestrina in quanto eccipiente. Essa ha ugualmente per oggetto il procedimento di preparazione di questi micro - granuli tramite estrusione - sferonizzazione, così come l'utilizzazione di una ciclodestrina in quanto eccipiente per la fabricazione di micro - granuli tramite estrusione - sferonizzazione, questi micro - granulari permettendo la liberazione controllata dei principi attivi farmaceutici, per la sanità animale o agrochimica.
IT94TO000406A 1993-05-28 1994-05-20 Micro-granuli ottenuti tramite estrusione-sferonizzazione contenenti una ciclodestrina. IT1265964B1 (it)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9306430A FR2705677B1 (fr) 1993-05-28 1993-05-28 Micro-granules obtenus par extrusion-sphéronisation contenant une cyclodextrine.

Publications (3)

Publication Number Publication Date
ITTO940406A0 ITTO940406A0 (it) 1994-05-20
ITTO940406A1 ITTO940406A1 (it) 1995-11-20
IT1265964B1 true IT1265964B1 (it) 1996-12-16

Family

ID=9447555

Family Applications (1)

Application Number Title Priority Date Filing Date
IT94TO000406A IT1265964B1 (it) 1993-05-28 1994-05-20 Micro-granuli ottenuti tramite estrusione-sferonizzazione contenenti una ciclodestrina.

Country Status (2)

Country Link
FR (1) FR2705677B1 (it)
IT (1) IT1265964B1 (it)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2721512A1 (fr) * 1994-06-28 1995-12-29 Maurice Jacob Formulation et procédé de préparation de sphéroïdes à base de solutions d'origine végétale.
TW377357B (en) * 1995-11-23 1999-12-21 Janssen Pharmaceutica Nv Process for preparing solid mixtures comprising cyclodextrins and active ingredients by melt-extrusion
SK67298A3 (en) * 1995-11-23 1998-11-04 Janssen Pharmaceutica Nv Solid mixtures of cyclodextrins prepared via melt-extrusion
NL1011307C1 (nl) * 1999-02-15 2000-08-17 Dsm Nv Werkwijze voor het vormgeven van (aard)alkalimetaalbenzoaatdeeltjes.
EP1252886A1 (en) * 2001-04-27 2002-10-30 Universiteit Gent Controlled release pharmaceutical pellet compositions
US7790201B2 (en) 2003-09-03 2010-09-07 Mallinckrodt Inc. Granular sustained release preparation and production thereof
PL1799195T3 (pl) * 2004-08-12 2016-09-30 Granulki zawierające paracetamol, nlpz i alkohol cukrowy wytwarzane przez wytłaczanie ze stopionego materiału
BE1028699B1 (fr) * 2020-10-13 2022-05-16 Eleonor Composition comprenant au moins un diterpène labdanique et son procédé de fabrication

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2804048B2 (ja) * 1987-09-11 1998-09-24 イー・アール・スクイブ・アンド・サンズ・インコーポレイテッド 高薬物含量医薬組成物およびその製造法
JP3191948B2 (ja) * 1990-04-12 2001-07-23 塩野義製薬株式会社 被覆製剤およびその製造法
WO1993007859A1 (en) * 1991-10-23 1993-04-29 Warner-Lambert Company Novel pharmaceutical pellets and process for their production

Also Published As

Publication number Publication date
ITTO940406A1 (it) 1995-11-20
FR2705677A1 (fr) 1994-12-02
FR2705677B1 (fr) 1995-08-11
ITTO940406A0 (it) 1994-05-20

Similar Documents

Publication Publication Date Title
PT1311285E (pt) Composicao farmaceutica liquida contendo um derivado de eritropoietina
PT97689A (pt) Processo para a preparacao de composicoes farmaceuticas incorporando como ingrediente activo isoxazol-4-carboxilamida e hidroxialquilideno-cianoacetamida
HUT52030A (en) Fungicide, insecticide and miticide compositions containing propene-carboxylic acid derivatives as active components and process for producing the active components
IT1098059B (it) Nuove preparazioni di microorganismi e procedimento per la loro produzione,come pure l'impiego delle stesse per la decomposizione di prodotti industriali organici di sintesi
IT8320301A0 (it) Preparazioni liquide di diidropiridine, procedimento per la loro preparazione cosi' come il loro impiego nella cura delle malattie.
DK0490772T3 (da) 1,4-disubstituerede piperaziner, fremgangsmåde til fremstilling heraf og farmaceutiske midler, der indeholder dem
ES2013067A6 (es) Un procedimiento para producir un derivado de piperazina.
NO20030724D0 (no) Anvendelse av derivater av valproinsyreamider og 2- valproensyreamider for terapi eller prevensjon av smerte- og/eller hodepinelidelser
MX9205922A (es) Composiciones de sales de antibiotico lipofilico oligosacarido.
IT1265964B1 (it) Micro-granuli ottenuti tramite estrusione-sferonizzazione contenenti una ciclodestrina.
BR9913782A (pt) Processo de preparação de uma formualação galênica que compreende fenofibrato como princìpio ativo, formulação galênica, medicamento e utilizações de um meio lìquido e de partìculas de fenofibrato
SE0002729D0 (sv) Novel compound form
TR200003451T2 (tr) Pirimidin-Aminometil-Piridin Türevleri, Hazırlanmaları ve helikobakter bakterinin kontrolünde kullanımları
DK15088A (da) Antibakterielt lyofiliseret praeparat
LU81501A1 (fr) Compositions pharmaceutiques comprenant de la trimethoprime,ainsi que des derives d'acides n-ethyl-gamma-pyridone-3-carboxyliques
IT8622579A0 (it) Derivati di azlattoni, processo per la loro preparazione e pesticidi contenenti questi composti come ingrediente attivo.
NO981594L (no) Behandling av infeksjoner forÕrsaket av Helicobacter pylori
ZA824649B (en) New optically active dipeptides, process for their preparation and pharmaceutical products containing these compounds
DE50212538D1 (de) Substituierte 5,6,6a,11b-tetrahydro-7-oxa-5-aza-benzoäcüfluoren-6-carbonsäurederivate als nmda-antagonisten
DE69115890D1 (de) Sterilisierende zusammensetzung
NO303640B1 (no) Ny forbindelse, Leustroducsin H, farmas°ytisk preparat som omfatter den, og dens anvendelse til fremstilling av et slikt preparat
UA37377A (uk) Спосіб отримання мазі для лікування захворювань, які викликані внутрішньоклітинними інфекційними агентами
HUP0000552A2 (hu) Egy O-(3-piperidino-2hidroxi-1-propil)-hidroximsav halogenidszármazék, annak alkalmazása, valamint ilyen származékot hatóanyagként tartalmazó gyógyászati készítmény
IT8124405A0 (it) Derivato dell'indoprofene, processo per la sua preparazione e composizioni terapeutiche che lo comprendono come principio attivo.
UA10118A (uk) Засіб для підвищення фізіологічної активності рослин пшениці в умовах посухи

Legal Events

Date Code Title Description
0001 Granted
TA Fee payment date (situation as of event date), data collected since 19931001

Effective date: 19970530